Abstract:Cardiovascular diseases (CVDs) represent a major concern for global health whose mechanistic understanding is complicated by a complex interplay between genetic predisposition and environmental factors. Specifically, heart failure (HF), encompassing dilated cardiomyopathy (DC), ischemic cardiomyopathy (ICM), and hypertrophic cardiomyopathy (HCM), is a topic of substantial interest in basic and clinical research. Here we used a Partial Correlation Coefficient-based algorithm (PCC) within the context of a meta-analysis framework, to construct a Gene Regulatory Network (GRN) that identifies key regulators whose activity is perturbed in Heart Failure. By integrating data from multiple independent studies, our approach unveiled crucial regulatory associations between transcription factors (TFs) and structural genes, emphasizing their pivotal roles in regulating metabolic pathways, such as fatty acid metabolism, oxidative stress response, epithelial-to-mesenchymal transition, and coagulation. In addition to known associations, our analysis also identified novel regulators, including the identification of TFs FPM315 and MOVO-B, which are implicated in dilated cardiomyopathies, and TEAD1 and TEAD2 in both dilated and ischemic cardiomyopathies. Moreover, we uncovered alterations in adipogenesis and oxidative phosphorylation pathways in hypertrophic cardiomyopathy, and discovered a role for IL2 STAT5 signaling in heart failure. Our findings underscore the importance of TFs activity in the initiation and progression of cardiac disease, highlighting their potential as pharmacological targets.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to construct a gene regulatory network (GRN) by using the Partial Correlation Coefficient (PCC) algorithm combined with a meta - analysis framework, in order to identify key regulators with abnormal activities in heart failure (HF). Specifically, the paper focuses on different manifestations of heart failure, including Dilated Cardiomyopathy (DC), Ischemic Cardiomyopathy (ICM), and Hypertrophic Cardiomyopathy (HCM). ### Main objectives of the paper: 1. **Construct a gene regulatory network**: Integrate data from multiple independent studies to construct a gene regulatory network that can reveal the key regulatory associations between transcription factors (TFs) and structural genes. 2. **Identify key regulators**: Identify key transcription factors with abnormal activities in heart failure and its different manifestations. These factors may play important roles in metabolic pathways, oxidative stress responses, epithelial - to - mesenchymal transition (EMT), and blood coagulation processes. 3. **Discover new regulatory factors**: In addition to known regulatory factors, it is also hoped to discover new regulatory factors, such as the transcription factors FPM315 and MOVO - B discovered in dilated cardiomyopathy, and TEAD1 and TEAD2 discovered in dilated and ischemic cardiomyopathy. 4. **Explore changes in metabolic pathways**: Study the changes in metabolic pathways in different forms of heart failure, such as the alterations in the lipogenesis and oxidative phosphorylation pathways discovered in hypertrophic cardiomyopathy. 5. **Reveal the role of signal pathways**: Explore the roles of the IL2 and STAT5 signal pathways in heart failure and verify whether these pathways can be used as potential pharmacological targets. ### Methods of the paper: - **Data collection**: Collect samples from multiple publicly available gene expression datasets, including healthy individuals and patients with different types of heart diseases. - **Differential expression analysis**: Calculate the gene expression differences between the disease group and the control group. - **Pathway activity analysis**: Calculate the pathway activity scores through Gene Set Variation Analysis (GSVA) and compare the differences between the disease group and the control group. - **MicroRNA (miRNA) analysis**: Identify miRNAs that are differentially expressed in different heart diseases. - **Transcription factor activity analysis**: Analyze the activity changes of transcription factors in different heart diseases. ### Contributions of the paper: - **Systematic construction of a gene regulatory network**: Through the meta - analysis method, a systematic gene regulatory network has been constructed, revealing the key regulatory mechanisms in heart failure and its different manifestations. - **Discovery of new regulatory factors**: New transcription factors have been discovered, and these factors may play important roles in the pathogenesis of heart failure. - **Potential therapeutic targets**: Provide new potential targets for the treatment of heart failure, especially those transcription factors and miRNAs that play key roles in metabolic pathways and signal pathways. In conclusion, this paper constructs a detailed gene regulatory network through comprehensive analysis of multiple datasets, aiming to deeply understand the molecular mechanisms of heart failure and its different manifestations and provide new clues for future drug development.

A meta-analysis approach to gene regulatory network inference identifies key regulators of cardiovascular diseases

A Meta-Analysis Approach to Gene Regulatory Network Inference Identifies Key Regulators of Cardiovascular Diseases

Identification of Underlying Hub Genes Associated with Hypertrophic Cardiomyopathy by Integrated Bioinformatics Analysis

Heart failure: advanced development in genetics and epigenetics.

Pgpm_a_314880 823..837

Regulatory network analysis based on integrated miRNA-TF reveals key genes in heart failure

Systematic analysis of molecular mechanisms of heart failure through the pathway and network-based approach

Mining Potential Drug Targets and Constructing Diagnostic Models for Heart Failure Based on Mirna-Mrna Networks

Association of genetically predicted human metabolomic gene expression with incident heart failure

Functional mutation, splice, distribution, and divergence analysis of impactful genes associated with heart failure and other cardiovascular diseases

Dissecting Regulatory Non-Coding Heart Disease GWAS Loci with High-Resolution 3D Chromatin Interactions Reveals Causal Genes with Pathophysiological Relevance to Heart Failure

Identification of biomarkers, pathways, and potential therapeutic targets for heart failure using next-generation sequencing data and bioinformatics analysis

CDKN1A As a Target of Senescence in Heart Failure: Insights from a Multiomics Study

Connecting intermediate phenotypes to disease using multi-omics in heart failure

The Identification of Key Genes and Biological Pathways in Heart Failure by Integrated Bioinformatics Analysis

Identification of candidate biomarkers and therapeutic agents for heart failure by bioinformatics analysis

Pathologic gene network rewiring implicates PPP1R3A as a central regulator in pressure overload heart failure

Identification of novel key genes and signaling pathways in hypertrophic cardiomyopathy: evidence from bioinformatics and next generation sequencing data analysis

Integrative Analysis of Bulk and Single-Cell RNA Sequencing Data Reveals Cell Types Involved in Heart Failure

A mechanistic framework for cardiometabolic and coronary artery diseases

The Genetic Factors Influencing Cardiomyopathies and Heart Failure across the Allele Frequency Spectrum